NO892340D0 - Farmasoeytiske sammensetninger. - Google Patents

Farmasoeytiske sammensetninger.

Info

Publication number
NO892340D0
NO892340D0 NO892340A NO892340A NO892340D0 NO 892340 D0 NO892340 D0 NO 892340D0 NO 892340 A NO892340 A NO 892340A NO 892340 A NO892340 A NO 892340A NO 892340 D0 NO892340 D0 NO 892340D0
Authority
NO
Norway
Prior art keywords
pharmaceutical compositions
ibuprofen
complexes
cyclodextrin
beta
Prior art date
Application number
NO892340A
Other languages
English (en)
Other versions
NO175039C (no
NO175039B (no
NO892340L (no
Inventor
Christopher Hunter
David Yau
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of NO892340D0 publication Critical patent/NO892340D0/no
Publication of NO892340L publication Critical patent/NO892340L/no
Publication of NO175039B publication Critical patent/NO175039B/no
Publication of NO175039C publication Critical patent/NO175039C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO892340A 1988-06-09 1989-06-07 Fremgangsmåte for fremstilling av cyklodekstrinkomplekser NO175039B (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813682A GB8813682D0 (en) 1988-06-09 1988-06-09 Pharmaceutical compositions

Publications (4)

Publication Number Publication Date
NO892340D0 true NO892340D0 (no) 1989-06-07
NO892340L NO892340L (no) 1989-12-11
NO175039B NO175039B (no) 1994-05-16
NO175039C NO175039C (no) 1994-08-24

Family

ID=10638367

Family Applications (1)

Application Number Title Priority Date Filing Date
NO892340A NO175039B (no) 1988-06-09 1989-06-07 Fremgangsmåte for fremstilling av cyklodekstrinkomplekser

Country Status (18)

Country Link
US (1) US5019563A (no)
EP (1) EP0346006B1 (no)
JP (1) JPH02243649A (no)
KR (1) KR910000138A (no)
AT (1) ATE83924T1 (no)
AU (1) AU609988B2 (no)
CA (1) CA1320192C (no)
DE (1) DE68904121T2 (no)
DK (1) DK280789A (no)
ES (1) ES2052914T3 (no)
FI (1) FI93692C (no)
GB (2) GB8813682D0 (no)
GR (1) GR3006729T3 (no)
IE (1) IE61616B1 (no)
NO (1) NO175039B (no)
NZ (1) NZ229204A (no)
PT (1) PT90760B (no)
ZA (1) ZA893913B (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
FR2660195B1 (fr) * 1990-03-28 1994-10-07 Crinex Sa Laboratoires Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique.
EP0505180B1 (en) * 1991-03-22 1996-10-09 Merck & Co. Inc. High-content ibuprofen lysinate pharmaceutical formulation
EP0519428B1 (en) * 1991-06-21 2000-09-20 Takeda Chemical Industries, Ltd. Cyclodextrin compositions with fumagillol derivates
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
IT1255007B (it) * 1991-07-01 1995-10-11 Altergon Sa Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono.
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
CN1088600C (zh) * 1993-07-31 2002-08-07 史密丝克莱恩比彻姆有限公司 布洛芬－β－环糊精配合物的用途
US5582351A (en) * 1993-08-09 1996-12-10 Tsau; Josef Convenient to use aspartame and method of making
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
CZ306394A3 (en) * 1993-12-14 1995-08-16 Lilly Co Eli Aqueous solution of inclusion complex of benzothiophene derivative with water-soluble cyclodextrins, process of its preparation and a pharmaceutical composition containing thereof
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6287603B1 (en) * 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
ES2171110B1 (es) * 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
KR100451485B1 (ko) * 2002-03-28 2004-10-06 주식회사종근당 푸마질롤 유도체 또는 그 염의 포접 화합물, 및 이를포함하는 약제학적 조성물
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
PL381799A1 (pl) * 2004-06-07 2007-07-09 Strides Arcolab Limited Kompozycja farmaceutyczna zawierająca trwały i klarowny roztwór leku przeciwzapalnego w miękkiej kapsułce żelatynowej i sposób jej wytwarzania
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR100730393B1 (ko) * 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
RU2008116871A (ru) * 2005-11-02 2009-12-10 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. (US) Органолептически приемлемые пероральные лекарственные формы ибупрофена, способы их приготовления и применения
PL1998762T3 (pl) * 2006-03-16 2011-04-29 Novartis Ag Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
EP2323976A4 (en) * 2008-08-14 2014-07-02 Shasun Chemicals And Drugs Ltd ARYLALKYLCARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION THEREOF AND GALENIC FORMS
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
ES2347754B8 (es) * 2009-04-27 2012-06-04 Laboratorio De Aplicaciones Farmacodinamicas, S.A Suspension oral de lisinato de ibuprofeno
DK2253329T3 (en) * 2009-04-27 2017-01-16 Laboratorio De Aplicaciones Farm S A Oral ibuprofen lysinate suspension.
US20120101159A1 (en) * 2009-04-27 2012-04-26 Laboratorio De Aplicaciones Farmacodinamicas, S.A. Ibuprofen lysinate oral suspension
JP2012530781A (ja) * 2009-06-22 2012-12-06 ワイス・エルエルシー イブプロフェンナトリウムタブレット、およびイブプロフェンナトリウムを含有する医薬組成物の製造方法
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
US10098964B2 (en) 2015-03-12 2018-10-16 The Board Of Trustees Of The University Of Illinois Inclusion complexes and methods for making the same
CN114588107B (zh) * 2022-04-06 2023-04-18 河北一品生物医药有限公司 一种布洛芬赖氨酸盐注射液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646837A (en) * 1979-09-27 1981-04-28 Kowa Yakuhin Kogyo Kk Preparation of ibuprofen clathrate compound
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
CA1298290C (en) * 1987-01-09 1992-03-31 Herand M. Markarian Solution ibuprofen complexes, compositions and processes for preparing the same

Also Published As

Publication number Publication date
JPH02243649A (ja) 1990-09-27
GB2219585A (en) 1989-12-13
PT90760A (pt) 1989-12-29
ATE83924T1 (de) 1993-01-15
NO175039C (no) 1994-08-24
AU3492789A (en) 1989-12-14
DK280789D0 (da) 1989-06-08
NO175039B (no) 1994-05-16
DK280789A (da) 1989-12-12
CA1320192C (en) 1993-07-13
GR3006729T3 (no) 1993-06-30
GB8813682D0 (en) 1988-07-13
NZ229204A (en) 1992-03-26
DE68904121D1 (de) 1993-02-11
NO892340L (no) 1989-12-11
IE891757L (en) 1989-12-09
GB8911938D0 (en) 1989-07-12
EP0346006B1 (en) 1992-12-30
KR910000138A (ko) 1991-01-29
ZA893913B (en) 1990-02-28
FI93692B (fi) 1995-02-15
US5019563A (en) 1991-05-28
GB2219585B (en) 1991-11-06
AU609988B2 (en) 1991-05-09
IE61616B1 (en) 1994-11-16
ES2052914T3 (es) 1994-07-16
FI892780A0 (fi) 1989-06-07
DE68904121T2 (de) 1993-05-06
FI892780A (fi) 1989-12-10
PT90760B (pt) 1994-10-31
EP0346006A1 (en) 1989-12-13
FI93692C (fi) 1995-05-26

Similar Documents

Publication Publication Date Title
NO892340L (no) Farmasoeytiske sammensetninger.
PL261349A1 (en) Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin
DK232989A (da) Antiviralt praeparat
IT8947539A0 (it) Sali cefalosporinici e relative composizioni iniettabili, nonche' procedimento di preparazione
ITTO920713A1 (it) Procedimento per la produzione di articoli vulcanizzabili e articoli cosi' ottenuti
FR2627493B1 (fr) Procede de preparation de derives d'isoquinoleine
MC1960A1 (fr) Derives d'acide hydrocinnamique
EP0239015A3 (en) Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
FR2651232B1 (fr) Produits d'addition de l'acide boronique de complexes technetium 99m-dioxime-imine.
ES2032209T3 (es) Derivados de proteinas que contienen hierro en forma altamente biodisponible, su preparacion y composiciones farmaceuticas que los contienen.
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
FR2504525B1 (fr) Procede de preparation d'oligopeptides lysine-tryptophane, de leurs derives et de leurs sels physiologiquement utilisables
IT8621934A0 (it) Procedimento per la preparazione di derivati salini dell'acido mercaptoetansolfonico.
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
FR2648816B1 (fr) Nouveaux derives diester d'octahydro-indolo-(2,3-a)-quinolizine et leurs sels et procede pour les preparer
IT8822479A0 (it) Sale di calcio biodisponibile e relative composizoni farmaceutiche.
IT8822047A0 (it) Acido 8 amino 1 idrossiottan 1,1difosfonico, suoi sali o derivati e relative composizioni farmaceutiche
IT8720774A0 (it) Metodo per la preparazione di amoxicillina sodica liofilizzata eprodotto cosi' ottenuto.
IT8867820A0 (it) Procedimento di preparazione di derivati dell'1,4-benzodiazepina-4-one
NO172492C (no) Fremgangsmaate for fremstilling av alkalimetall- eller jordalkalimetallsalter av n5-formyl-5,6,7,8-tetrahydrofolsyre
MY107599A (en) Sucralfate suspension compounds.
IT1229722B (it) Procedimento per la preparazione di derivati dell'acido fenilacetico.
IT8620211A0 (it) Sale di acido 5'-adenilico, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8721255A0 (it) 2 tiolpropionil arginine, loro sali, procedimento per la loro preparazione e relative composizioni farmaceutiche.